Symptomatic severe acute respiratory syndrome coronavirus 2 reinfection in a lupus patient treated with hydroxychloroquine: a case report

BACKGROUND: Hydroxychloroquine and chloroquine have been used for hospitalized coronavirus disease 2019 patients because of their antiviral and anti-inflammatory function. However, little research has been published on the impact of the immunomodulatory effect of (hydroxy)chloroquine on humoral immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Muyldermans, Astrid, Maes, Piet, Wawina-Bokalanga, Tony, Anthierens, Tine, Goldberg, Olivier, Bartiaux, Magali, Soetens, Oriane, Wybo, Ingrid, Van den Wijngaert, Sigi, Piérard, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620303/
https://www.ncbi.nlm.nih.gov/pubmed/34836543
http://dx.doi.org/10.1186/s13256-021-03159-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620303/
https://www.ncbi.nlm.nih.gov/pubmed/34836543
http://dx.doi.org/10.1186/s13256-021-03159-9

Ejemplares similares